Semaglutide may be unsuitable or require additional caution in patients who: are pregnant, breastfeeding or trying to conceive have a history of pancreatitis have severe gastrointestinal disease have delayed stomach emptying have significant kidney or liver impairment use insulin or medicines that can cause hypoglycaemia have diabetic retinopathy have an active or previous eating disorder have experienced a serious allergic reaction to semaglutide already use another GLP-1 or GIP/GLP-1 medicine are due to undergo surgery, sedation or general anaesthesia These factors are not all automatic exclusions
Check Our Offers Table of Contents: Why is GLP-1 therapy popular for medical weight loss
Monitoring non-HDL cholesterol provides a comprehensive measure of cardiovascular risk, helping guide lifestyle changes or treatment to protect heart health
For groups of 10 or more, a nurse will come to your facility
Its bacteriostatic properties help mitigate microbial interference that could otherwise affect the validity and reproducibility of research outcomes
Targeted GLP-1 companion supplementation, guided by laboratory values and clinical context, may help support nutritional adequacy during GLP-1 therapy